Jubashi A, Nakayama I, Koganemaru S, Sakamoto N, Oda S, Matsubara Y, Miyashita Y, Sato S, Ushiyama S, Kobayashi A, Okazaki U, Okemoto D, Yamamoto K, Mishima S, Kotani D, Kawazoe A, Hashimoto T, Nakamura Y, Kuboki Y, Bando H, Kojima T, Yoshino T, Miyaaki H, Nakao K, Shitara K. Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancer. Gastric Cancer 28(1):63-73 Jan 2025
https://pubmed.ncbi.nlm.nih.gov/39487862

Jubashi A, Kotani D, Kojima T, Takebe N, Shitara K. Current landscape of targeted therapy in esophageal squamous cell carcinoma. Curr Probl Cancer 53:101152 Dec 2024
https://pubmed.ncbi.nlm.nih.gov/39454516

Matsubara Y, Bando H, Kotani D, Kagawa Y, Harada K, Osumi H, et al. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer. ESMO Gastrointestinal Oncology. 2024 Jun 1;4:100066.
https://www.esmogastro.org/article/S2949-8198(24)00027-X/pdf

Takei S. Tanaka Y, Lin YT, Koyama S, Fukuoka S, Hara H, Nakamura Y, Kuboki Y, Kotani D, Kojima T, Bando H, Mishima S, Ueno T, Kojima S, Wakabayashi M, Sakamoto N, Kojima M, Kuwata T, Yoshino T, Nishikawa H, Mano H, Endo I, Shitara K, Kawazoe A.  Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer. J Immunother Cancer 12(2):e008210 Feb 2024
https://pubmed.ncbi.nlm.nih.gov/38336371

Aoki Y. Nakamura Y, Denda T, Ohta T, Esaki T, Shiozawa M, Yamaguchi K, Yamazaki K, Sunakawa Y, Kato T, Okano N, Taniguchi H, Sato T, Oki E, Nishina T, Komatsu Y, Matsuhashi N, Goto M, Yasui H, Ohtsubo K, Moriwaki T, Takahashi N, Horita Y, Boku S, Wakabayashi M, Ikeno T, Mitani R, Yuasa M, Yoshino T.  Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy.  JCO Precis Oncol. 2023 Jun:7:e2200688.
https://pubmed.ncbi.nlm.nih.gov/37343204

Seiya Sato, Yoshiaki Nakamura, Eiji Oki, Takayuki Yoshino. Molecular Residual Disease-guided Adjuvant Treatment in Resected Colorectal Cancer: Focus on CIRCULATE-Japan. Clin Colorectal Cancer. 2023 Mar;22(1):53-58.
https://pubmed.ncbi.nlm.nih.gov/36567192

Akinori Kobayashi et al. Association between ctDNA levels, timing of blood collection, and overall survival in metastatic colorectal cancer. 2025ASCO-GI 2025/1/25
https://ascopubs.org/doi/10.1200/JCO.2025.43.4_suppl.245

Yu Miyashita et al. Clinical validation of plasma circulating-tumor DNA assay using highly sensitive Safe-SeqS technology for detecting RAS and BRAF V600E in metastatic colorectal cancer. 2025ASCO-GI 2025/1/25
https://ascopubs.org/doi/10.1200/JCO.2025.43.4_suppl.50

Yuki Matsubara et al. Real-world evidence on genomic profiles and survival outcomes in patients with HER2-positive metastatic colorectal cancer. 2025ASCO-GI 2025/1/25
https://ascopubs.org/doi/10.1200/JCO.2025.43.4_suppl.58

Shinpei Ushiyama et al. Molecular landscape of neuroendocrine neoplasms using tissue and blood-based genotyping in MONSTAR-SCREEN-2 2024ESMO-Asia 2024/12/7
https://www.annalsofoncology.org/article/S0923-7534(24)04321-7/fulltext

Seiya Sato et al. Fibroblast growth factor receptor 2 isoform IIIb (FGFR2b) protein overexpression and biomarker overlap in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC) 2024ESMO 2024/9/16
https://www.annalsofoncology.org/article/S0923-7534(24)03005-9/fulltext

Yuki Matsubara et al. A multicenter retrospective study of ramucirumab-containing chemotherapy for gastrointestinal neuroendocrine carcinoma after platinum-based chemotherapy (WJOG13420G: RAM-NEC) 2024ESMO-GI 2024/6/27
https://www.annalsofoncology.org/article/S0923-7534(24)00361-2/fulltext

Yu Aoki et al. Clinical utility of upfront circulating tumor DNA (ctDNA) genotyping to guide first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC): A GOZILA substudy. 2024ASCO-GI  2024/1/20
https://ascopubs.org/doi/10.1200/JCO.2024.42.3_suppl.157

Shogo Takei et al. Longitudinal circulating tumor DNA monitoring in patients with esophageal squamous cell carcinoma. 2023ASCO 2023/6/3
https://ascopubs.org/doi/10.1200/JCO.2023.41.16_suppl.3041

牛山心平　Oral Session　「Molecular landscape of neuroendocrine neoplasms using tissue and blood-based genotyping in MONSTAR-SCREEN-2」第22回日本臨床腫瘍学会学術集会　2025/3/8

佐藤　清哉　Mini Oral Session「Clinical outcome of encorafenib, cetuximab and binimetinib in BRAF V600E-mutated metastatic colorectal cancer.」第21回日本臨床腫瘍学会学術集会　2024/2/24

重橋　周　Mini Oral Session「Safety and Efficacy of Preoperative FOLFOX in Cisplatin-ineligible Patients With Esophageal Squamous Cell Carcinoma.」第21回日本臨床腫瘍学会学術集会　2024/2/23